- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Late-life Depression in Argentina
Total 65 results
-
Janssen Research & Development, LLCCompletedDepressive Disorder | Psychotic Disorders | Schizophrenia | Bipolar DisorderUnited States, Belgium, Germany, Spain, Argentina, Brazil, Bulgaria
-
Janssen Research & Development, LLCRecruitingAnhedonia | Depressive Disorder, MajorKorea, Republic of, United States, China, Taiwan, Slovakia, Brazil, Poland, Argentina, Bulgaria, Czechia, South Africa, Canada, United Kingdom, France
-
TakedaCompletedCrohn Disease | Colitis, Ulcerative | Inflammatory Bowel DiseaseArgentina
-
Daniel Serrani AzcurraZarebski Graciela, Kabanchik Alicia, Marconi AraceliRecruitingDepression | Dementia of Alzheimer Type | Dementia Frontotemporal | Narcissistic Personality Disorder | Personality ChangeArgentina
-
Janssen-Cilag, S.A.CompletedDepressive Disorder, Treatment-ResistantBrazil, Argentina, Mexico, Colombia
-
EMD SeronoCompletedMultiple SclerosisUnited States, Australia, France, Italy, Turkey, United Kingdom, Austria, Germany, Israel, Argentina, Norway, Spain
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaSpain, Germany, United States, Austria, Czechia, United Kingdom, Argentina, Hungary, France, Canada, Chile
-
AbbVieCompletedChronic Lymphocytic Leukemia (CLL)Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Mitsubishi Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
-
University of ChileColumbia UniversityRecruitingDepression | Covid-19 | Anxiety | Mental Health Disorder | SARS-CoV-2 | Stress DisorderUnited States, Italy, Argentina, Armenia, Australia, Bolivia, Chile, Costa Rica, Czechia, Germany, Guatemala, Lebanon, Mexico, Netherlands, Nigeria, Puerto Rico, Saudi Arabia, Spain, Tunisia, Turkey, Venezuela
-
TakedaActive, not recruitingPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) | Ph+ Mixed Phenotype Acute Leukemia (MPAL) | Philadelphia Chromosome-Like ALL (Ph-like ALL)United States, France, Korea, Republic of, China, Spain, United Kingdom, Czechia, Portugal, Brazil, Argentina, Italy, Australia, Mexico, Netherlands, Poland
-
GlaxoSmithKlineCompletedAnaemiaUnited States, Canada, France, Russian Federation, Spain, Australia, United Kingdom, Romania, Brazil, Korea, Republic of, Italy, Poland, Argentina, Mexico